Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zoetis Inc. (ZTS)
USD75.39
-0.17 (-0.23%)
US NYSE S&P 500
Healthcare Drug Manufacturers - General
Address
10 Sylvan Way 7054
Parsippany, NJ, US
Parsippany, NJ, US
CEO
Kristin C. Peck
Website
zoetis.com
IPO
2013-02-01
CIK 1555280 ISIN US98978V1035
Also trades on
Deutsche Börse · ZOE.DE (EUR)
London Stock Exchange · 0M3Q.L (USD)
New York Stock Exchange · ZTS (USD)
Description
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| PFIZER INC. | PFE | 2013-05-22 | View |
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2013-06-21 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD75.39
-0.17 (-0.23%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
0.74
Float Shares
421.30M
Free Float %
99.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.44% | -15.44% | -34.95% | -38.98% | -36.77% | -39.06% | -52.65% | -58.25% | -54.37% | +65.77% | +147.24% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (30 ratings, all time)
Hold
Price Targets & DCF
Current price
75.39
Low
99.00
+31.3%
Consensus
133.57
+77.2%
Median
136.00
+80.4%
High
160.00
+112.2%
DCF (Unlevered)
175.74
+133.1%
DCF (Levered)
169.41
+124.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
62% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 9 | 0 |
| Hold | 8 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
130.00
+72.4%
|
| Last Quarter | 2 |
145.00
+92.3%
|
| Last Year | 11 |
151.82
+101.4%
|
| All Time | 22 |
183.50
+143.4%
|
Quality scores
Altman Z-Score
4.68
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
8 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - General: +6.6%+2.3% Q1'26: +1.9% (vs Q1'25)
-
EPS growth Drug Manufacturers - General: +18.2%+10.1% Q1'26: +0.7% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - General: +36.0%+23.7% Q1'26: +12.9% (vs Q1'25)
-
EBIT margin Drug Manufacturers - General: +19.4%+37.8% ★ Q1'26: +36.3% (vs Q1'25)
-
ROIC Drug Manufacturers - General: +10.2%+27.1% ★ Q1'26: +175.6% (vs Q1'25)
-
Share dilution Drug Manufacturers - General: +0.0%-2.4% ★ Q1'26: -5.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - General: -0.29×2.33× Q1'26: 0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 9 EPS Ana. |
Dec 2027 14 Rev. Ana. 12 EPS Ana. |
Dec 2028 12 Rev. Ana. 5 EPS Ana. |
Dec 2029 11 Rev. Ana. 1 EPS Ana. |
Dec 2030 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.56B
est: 4.40B (+3.6%)
|
4.79B
est: 4.51B (+6.2%)
|
4.77B
est: 4.74B (+0.6%)
|
4.89B
est: 4.89B (+0.0%)
|
5.31B
est: 5.25B (+1.1%)
|
5.83B
est: 5.79B (+0.6%)
|
6.26B
est: 6.23B (+0.6%)
|
6.68B
est: 6.60B (+1.1%)
|
7.78B
est: 7.74B (+0.4%)
|
8.08B
est: 8.04B (+0.5%)
|
8.54B
est: 8.92B (-4.2%)
|
9.26B
est: 9.25B (+0.1%)
|
9.47B
est: 9.44B (+0.3%)
|
9.82B
9.76B – 9.93B
+4.0% YoY
|
10.25B
10.06B – 10.48B
+4.4% YoY
|
10.78B
10.71B – 10.84B
+5.1% YoY
|
11.24B
11.03B – 11.47B
+4.3% YoY
|
11.75B
11.53B – 11.99B
+4.5% YoY
|
| EBITDA |
1.01B
est: 976.26M (+3.5%)
|
1.14B
est: 1.07B (+6.8%)
|
868.00M
est: 724.64M (+19.8%)
|
1.63B
est: 1.45B (+12.6%)
|
1.94B
est: 1.85B (+5.1%)
|
2.21B
est: 2.05B (+7.9%)
|
2.46B
est: 2.24B (+9.5%)
|
2.69B
est: 1.73B (+55.6%)
|
3.17B
est: 2.75B (+15.4%)
|
3.36B
est: 3.12B (+7.8%)
|
3.69B
est: 4.03B (-8.6%)
|
3.87B
est: 4.18B (-7.4%)
|
4.07B
est: 4.27B (-4.7%)
|
4.44B
4.41B – 4.49B
+4.0% YoY
|
4.64B
4.55B – 4.74B
+4.4% YoY
|
4.87B
4.84B – 4.90B
+5.1% YoY
|
5.08B
4.99B – 5.19B
+4.3% YoY
|
5.31B
5.21B – 5.42B
+4.5% YoY
|
| EBIT |
801.00M
est: 788.04M (+1.6%)
|
937.00M
est: 910.90M (+2.9%)
|
669.00M
est: 904.84M (-26.1%)
|
1.39B
est: 1.24B (+12.1%)
|
1.70B
est: 1.64B (+3.6%)
|
1.90B
est: 1.74B (+9.2%)
|
2.04B
est: 1.86B (+10.0%)
|
2.25B
est: 1.84B (+21.8%)
|
2.72B
est: 2.44B (+11.8%)
|
2.89B
est: 2.80B (+3.5%)
|
3.19B
est: 3.64B (-12.2%)
|
3.38B
est: 3.78B (-10.6%)
|
3.58B
est: 3.85B (-7.1%)
|
4.01B
3.98B – 4.05B
+4.0% YoY
|
4.19B
4.11B – 4.28B
+4.4% YoY
|
4.40B
4.37B – 4.43B
+5.1% YoY
|
4.59B
4.50B – 4.68B
+4.3% YoY
|
4.80B
4.71B – 4.89B
+4.5% YoY
|
| Net Income |
504.00M
est: 485.10M (+3.9%)
|
583.00M
est: 546.86M (+6.6%)
|
339.00M
est: 276.52M (+22.6%)
|
821.00M
est: 728.45M (+12.7%)
|
864.00M
est: 821.11M (+5.2%)
|
1.43B
est: 1.32B (+7.9%)
|
1.50B
est: 1.38B (+8.6%)
|
1.64B
est: 1.33B (+22.8%)
|
2.04B
est: 1.77B (+15.2%)
|
2.11B
est: 2.01B (+5.0%)
|
2.34B
est: 2.27B (+3.1%)
|
2.49B
est: 2.61B (-4.8%)
|
2.67B
est: 2.81B (-4.9%)
|
3.06B
3.01B – 3.11B
+8.9% YoY
|
3.31B
3.18B – 3.45B
+8.2% YoY
|
3.61B
3.45B – 3.76B
+8.8% YoY
|
3.89B
3.80B – 4.00B
+7.9% YoY
|
4.18B
4.08B – 4.29B
+7.3% YoY
|
| SGA |
1.43B
est: 1.55B (-8.1%)
|
1.51B
est: 1.54B (-1.5%)
|
1.40B
est: 1.31B (+7.3%)
|
1.32B
est: 1.22B (+8.0%)
|
1.33B
est: 1.27B (+4.4%)
|
1.48B
est: 1.38B (+7.5%)
|
1.64B
est: 1.51B (+8.6%)
|
1.73B
est: 1.42B (+21.1%)
|
2.00B
est: 1.77B (+13.3%)
|
2.01B
est: 2.02B (-0.5%)
|
2.15B
est: 2.25B (-4.2%)
|
2.32B
est: 2.33B (-0.5%)
|
2.38B
est: 2.38B (0.0%)
|
2.47B
2.46B – 2.50B
+4.0% YoY
|
2.58B
2.53B – 2.64B
+4.4% YoY
|
2.71B
2.70B – 2.73B
+5.1% YoY
|
2.83B
2.78B – 2.89B
+4.3% YoY
|
2.96B
2.90B – 3.02B
+4.5% YoY
|
| EPS |
1.01
est: 1.32 (-23.5%)
|
1.16
est: 1.39 (-16.5%)
|
0.68
est: 1.73 (-60.6%)
|
1.66
est: 1.94 (-14.6%)
|
1.76
est: 2.37 (-25.7%)
|
2.96
est: 3.12 (-5.0%)
|
3.14
est: 3.61 (-13.0%)
|
3.44
est: 3.80 (-9.4%)
|
4.29
est: 4.67 (-8.1%)
|
4.51
est: 4.88 (-7.6%)
|
5.08
est: 5.12 (-0.7%)
|
5.47
est: 5.89 (-7.1%)
|
6.03
est: 6.34 (-4.9%)
|
6.96
6.79 – 7.01
+9.8% YoY
|
7.49
7.17 – 7.76
+7.6% YoY
|
8.11
7.78 – 8.48
+8.3% YoY
|
8.77
8.56 – 9.00
+8.1% YoY
|
9.41
9.18 – 9.66
+7.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-28 | UBS | Neutral | Neutral | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.22B
OE per share TTM
5.06
Owner's Yield
5.80%
Maintenance CapEx ratio
15.67%
Maint CapEx / Avg PPE
37.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
742
Total invested
7.78B
Insider transactions (90d)
1
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 52-0556948 | 41.24M | 8.30% | 12.05M | — | 41.24M | — | IA | Maryland | 2017-02-07 | ↗ |
| 2 | (1) BlackRock, Inc. | 40.32M | 8.50% | 35.03M | — | 40.32M | — | HC | Delaware | 2022-02-03 | ↗ |
| 3 | The Vanguard Group - 23-1945930 | 37.33M | 7.89% | — | 802.2K | 35.37M | 1.96M | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 4 | 04-2683227 | 29.28M | 5.86% | — | 8.35M | — | — | IA | Massachusetts | 2014-02-14 | ↗ |
| 5 | STATE STREET CORPORATION | 25.06M | 5.00% | — | 25.06M | — | 25.06M | HC | BOSTON MASSACHUSETTS | 2014-02-05 | ↗ |
| 6 | Lazard Asset Management LLC | 12.69M | 11.00% | 5.05M | — | 12.69M | — | IA | Delaware | 2013-08-12 | ↗ |
| 7 | Steven A. Cohen | 4.86M | 1.00% | — | 4.86M | — | — | IN | United States | 2014-02-14 | ↗ |
| 8 | S.A.C. Capital Advisors, Inc. | 4.75M | 0.90% | — | 4.75M | — | — | CO | Delaware | 2014-02-14 | ↗ |
| 9 | S.A.C. Capital Associates, LLC | 3.80M | 0.80% | — | 3.80M | — | — | OO | Anguilla, British West Indies | 2014-02-14 | ↗ |
| 10 | CR Intrinsic Investors, LLC | 110.0K | 4.00% | — | 110.0K | — | — | OO | Delaware | 2014-02-14 | ↗ |
| 11 | S.A.C. Global Investors LLP | — | 0.00% | — | — | — | — | OO | England and Wales | 2014-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
742
-977 vs prev Q
New positions
61
Closed positions
993
Increased
361
Reduced
277
Put/Call ratio
0.00
Calls held
1.9K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 47.78M +5.5M (+12.9%) | 6.01B -178.5M (-2.9%) | 10.90% +1.399 pp | 0.09% -0.006 pp | USD69.92 +79.9% | 52 qtrs — |
| 2 | BLACKROCK, INC. | 37.35M +1.2M (+3.2%) | 4.70B -597.1M (-11.3%) | 8.52% +0.391 pp | 0.08% -0.013 pp | USD192.85 -34.8% | 6 qtrs — |
| 3 | STATE STREET CORP | 19.80M +149.4K (+0.8%) | 2.49B -384.0M (-13.4%) | 4.52% +0.104 pp | 0.08% -0.016 pp | USD60.94 +106.5% | 51 qtrs — |
| 4 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 15.89M +— (+0.0%) | 2.00B -325.8M (-14.0%) | 3.59% +0.018 pp | 1.57% -0.368 pp | USD30.61 +311.0% | 51 qtrs — |
| 5 | MORGAN STANLEY | 15.47M -1.5M (-8.7%) | 1.95B -533.3M (-21.5%) | 3.53% -0.277 pp | 0.12% -0.034 pp | USD134.38 -6.4% | 51 qtrs — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 11.39M +2.9M (+33.4%) | 1.43B +183.9M (+14.7%) | 2.57% +0.651 pp | 0.25% +0.033 pp | USD154.82 -18.7% | 52 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 11.33M +189.2K (+1.7%) | 1.42B -203.3M (-12.5%) | 2.59% +0.083 pp | 0.09% -0.016 pp | USD105.52 +19.2% | 52 qtrs — |
| 8 | NORGES BANK | 5.84M +5.8M (+100.0%) | 734.43M +734.4M (+100.0%) | 1.32% +1.318 pp | 0.08% +0.079 pp | USD125.82 +0.0% | 1 qtrs NEW |
| 9 | NORTHERN TRUST CORP | 5.75M -254.3K (-4.2%) | 723.29M -155.1M (-17.7%) | 1.30% -0.052 pp | 0.09% -0.020 pp | USD82.14 +53.2% | 51 qtrs — |
| 10 | POLEN CAPITAL MANAGEMENT LLC | 5.56M -2.0M (-26.0%) | 699.89M -400.0M (-36.4%) | 1.26% -0.433 pp | 2.99% -0.582 pp | USD131.73 -4.5% | 33 qtrs — |
| 11 | DEUTSCHE BANK AG\ | 5.56M +891.9K (+19.1%) | 699.33M +16.6M (+2.4%) | 1.26% +0.207 pp | 0.23% -0.001 pp | USD149.58 -15.9% | 50 qtrs — |
| 12 | NORDEA INVESTMENT MANAGEMENT AB | 4.93M +2.2M (+79.2%) | 622.22M +225.2M (+56.7%) | 1.11% +0.495 pp | 0.53% +0.187 pp | USD141.14 -10.9% | 51 qtrs — |
| 13 | UNISPHERE ESTABLISHMENT | 4.80M +— (+0.0%) | 603.94M -98.4M (-14.0%) | 1.10% +0.017 pp | 4.51% -0.992 pp | USD190.53 -34.0% | 9 qtrs — |
| 14 | WELLS FARGO & COMPANY/MN | 4.79M -1.1M (-18.8%) | 602.63M -260.8M (-30.2%) | 1.09% -0.233 pp | 0.11% -0.054 pp | USD134.82 -6.7% | 52 qtrs — |
| 15 | BANK OF AMERICA CORP /DE/ | 4.50M -1.5M (-24.7%) | 566.74M -308.3M (-35.2%) | 1.03% -0.316 pp | 0.04% -0.018 pp | USD116.36 +8.1% | 52 qtrs — |
| 16 | BANK OF NEW YORK MELLON CORP | 4.31M +584.5K (+15.7%) | 541.71M -2.7M (-0.5%) | 0.97% +0.136 pp | 0.10% -0.009 pp | USD110.13 +14.2% | 52 qtrs — |
| 17 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 4.24M -72.3K (-1.7%) | 533.96M -97.1M (-15.4%) | 0.96% -0.012 pp | 0.36% -0.092 pp | USD155.97 -19.3% | 51 qtrs — |
| 18 | BROWN ADVISORY INC | 4.05M -676.1K (-14.3%) | 509.27M -181.9M (-26.3%) | 0.92% -0.138 pp | 0.71% -0.189 pp | USD138.36 -9.1% | 45 qtrs — |
| 19 | AMUNDI | 4.00M +1.4M (+51.2%) | 503.44M +118.5M (+30.8%) | 0.91% +0.319 pp | 0.14% +0.013 pp | USD155.81 -19.2% | 19 qtrs — |
| 20 | FUNDSMITH LLP | 3.90M +285.7K (+7.9%) | 490.80M -38.2M (-7.2%) | 0.89% +0.078 pp | 2.87% +0.195 pp | USD158.09 -20.4% | 21 qtrs — |
| 21 | JANUS HENDERSON GROUP PLC | 3.88M +1.6M (+69.6%) | 488.70M +153.5M (+45.8%) | 0.88% +0.361 pp | 0.22% +0.066 pp | USD145.10 -13.3% | 51 qtrs — |
| 22 | UBS ASSET MANAGEMENT AMERICAS INC | 3.83M -177.9K (-4.4%) | 481.43M -104.5M (-17.8%) | 0.86% -0.037 pp | 0.10% -0.025 pp | USD145.52 -13.5% | 52 qtrs — |
| 23 | ALLIANCEBERNSTEIN L.P. | 3.70M -540.9K (-12.8%) | 465.59M -155.0M (-25.0%) | 0.84% -0.108 pp | 0.15% -0.048 pp | USD115.10 +9.3% | 52 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.65M +6.7K (+0.2%) | 459.56M -73.9M (-13.9%) | 0.82% +0.005 pp | 0.07% -0.014 pp | USD102.66 +22.6% | 52 qtrs — |
| 25 | LEGAL & GENERAL GROUP PLC | 3.55M +138.7K (+4.1%) | 447.23M -52.6M (-10.5%) | 0.80% +0.035 pp | 0.10% -0.013 pp | USD100.34 +25.4% | 51 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 3.43M -1.2M (-25.3%) | 431.07M -240.2M (-35.8%) | 0.77% -0.257 pp | 0.05% -0.029 pp | USD163.88 -23.2% | 52 qtrs — |
| 27 | INVESCO LTD. | 3.36M -9.1K (-0.3%) | 423.00M -70.2M (-14.2%) | 0.77% +0.010 pp | 0.06% -0.013 pp | USD156.15 -19.4% | 52 qtrs — |
| 28 | NUVEEN, LLC | 3.28M -387.2K (-10.5%) | 413.19M -124.0M (-23.1%) | 0.75% -0.075 pp | 0.11% -0.034 pp | USD164.65 -23.6% | 4 qtrs — |
| 29 | DIAMOND HILL CAPITAL MANAGEMENT INC | 3.16M +465.8K (+17.3%) | 397.42M +3.4M (+0.9%) | 0.71% +0.108 pp | 2.04% +0.166 pp | USD143.30 -12.2% | 2 qtrs — |
| 30 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.04M +340.6K (+12.6%) | 382.30M -12.4M (-3.2%) | 0.69% +0.087 pp | 0.22% -0.025 pp | USD150.60 -16.5% | 6 qtrs — |
| 31 | DIMENSIONAL FUND ADVISORS LP | 2.83M +41.6K (+1.5%) | 356.65M -51.9M (-12.7%) | 0.64% +0.012 pp | 0.07% -0.013 pp | USD105.34 +19.4% | 51 qtrs — |
| 32 | UBS GROUP AG | 2.83M +17.7K (+0.6%) | 355.73M -55.4M (-13.5%) | 0.65% +0.014 pp | 0.06% -0.007 pp | USD164.20 -23.4% | 45 qtrs — |
| 33 | SWEDBANK AB | 2.73M +297.7K (+12.2%) | 344.07M -12.5M (-3.5%) | 0.62% +0.070 pp | 0.33% -0.029 pp | USD158.86 -20.8% | 20 qtrs — |
| 34 | PICTET ASSET MANAGEMENT HOLDING SA | 2.41M -276.5K (-10.3%) | 302.68M -89.6M (-22.8%) | 0.54% -0.059 pp | 0.29% -0.084 pp | USD169.48 -25.8% | 10 qtrs — |
| 35 | VAN ECK ASSOCIATES CORP | 2.39M +1.7M (+269.0%) | 300.34M +205.7M (+217.3%) | 0.54% +0.399 pp | 0.25% +0.160 pp | USD129.90 -3.1% | 50 qtrs — |
| 36 | BANQUE PICTET & CIE SA | 2.38M -152.7K (-6.0%) | 299.30M -71.1M (-19.2%) | 0.54% -0.032 pp | 1.75% -0.398 pp | USD115.29 +9.1% | 35 qtrs — |
| 37 | JPMORGAN CHASE & CO | 2.24M -371.4K (-14.2%) | 281.40M -100.2M (-26.3%) | 0.51% -0.081 pp | 0.02% -0.005 pp | USD166.71 -24.5% | 51 qtrs — |
| 38 | FIL LTD | 2.13M +1.7M (+372.2%) | 268.55M +202.4M (+306.0%) | 0.48% +0.380 pp | 0.20% +0.149 pp | USD133.56 -5.8% | 35 qtrs — |
| 39 | MONTRUSCO BOLTON INVESTMENTS INC. | 2.17M +1.6M (+256.7%) | 266.89M +178.0M (+200.1%) | 0.49% +0.353 pp | 3.33% +2.291 pp | USD137.51 -8.5% | 13 qtrs — |
| 40 | PRINCIPAL FINANCIAL GROUP INC | 2.06M -135.3K (-6.2%) | 258.91M -62.0M (-19.3%) | 0.46% -0.028 pp | 0.13% -0.030 pp | USD148.18 -15.1% | 52 qtrs — |
| 41 | BLS CAPITAL FONDSMAEGLERSELSKAB A/S | 1.98M +509.6K (+34.7%) | 248.70M +34.0M (+15.9%) | 0.45% +0.116 pp | 8.43% +1.043 pp | USD152.10 -17.3% | 4 qtrs — |
| 42 | AMERIPRISE FINANCIAL INC | 1.94M -1.4M (-41.2%) | 243.75M -242.0M (-49.8%) | 0.44% -0.303 pp | 0.06% -0.057 pp | USD160.38 -21.5% | 51 qtrs — |
| 43 | VERITAS ASSET MANAGEMENT LLP | 1.76M -24.3K (-1.4%) | 221.70M -39.7M (-15.2%) | 0.40% +0.001 pp | 2.27% -0.524 pp | USD172.58 -27.1% | 7 qtrs — |
| 44 | BROWN BROTHERS HARRIMAN & CO | 1.67M -204.9K (-10.9%) | 210.15M -64.2M (-23.4%) | 0.38% -0.044 pp | 1.15% -0.525 pp | USD32.11 +291.8% | 50 qtrs — |
| 45 | ROYAL BANK OF CANADA | 1.63M -821.6K (-33.4%) | 205.68M -153.7M (-42.8%) | 0.37% -0.179 pp | 0.03% -0.025 pp | USD113.59 +10.8% | 51 qtrs — |
| 46 | ASSENAGON ASSET MANAGEMENT S.A. | 1.63M +935.4K (+134.4%) | 205.29M +103.4M (+101.5%) | 0.37% +0.212 pp | 0.28% +0.143 pp | USD135.20 -6.9% | 21 qtrs — |
| 47 | FIRST TRUST ADVISORS LP | 1.58M +94.3K (+6.3%) | 198.76M -18.6M (-8.6%) | 0.36% +0.027 pp | 0.14% -0.017 pp | USD149.05 -15.6% | 51 qtrs — |
| 48 | IMPAX ASSET MANAGEMENT GROUP PLC | 1.58M -116.3K (-6.9%) | 198.46M -49.4M (-19.9%) | 0.36% -0.024 pp | 1.24% -0.205 pp | USD154.61 -18.6% | 25 qtrs — |
| 49 | TD ASSET MANAGEMENT INC | 1.56M -17.0K (-1.1%) | 196.78M -34.5M (-14.9%) | 0.35% -0.002 pp | 0.16% -0.030 pp | USD169.08 -25.6% | 51 qtrs — |
| 50 | — | 1.54M +— (+0.0%) | 193.40M -31.5M (-14.0%) | 0.35% +0.002 pp | 1.42% -0.383 pp | USD166.35 -24.4% | 10 qtrs — |
| 51 | CIBC PRIVATE WEALTH GROUP, LLC | 1.48M -196.5K (-11.7%) | 186.82M -59.2M (-24.1%) | 0.34% -0.043 pp | 0.32% -0.105 pp | USD159.21 -21.0% | 48 qtrs — |
| 52 | CAPITAL RESEARCH GLOBAL INVESTORS | 1.43M +6.5K (+0.5%) | 179.82M -28.3M (-13.6%) | 0.32% +0.003 pp | 0.03% -0.006 pp | USD163.07 -22.8% | 25 qtrs — |
| 53 | COMGEST GLOBAL INVESTORS S.A.S. | 1.39M -61.3K (-4.2%) | 175.23M -37.5M (-17.6%) | 0.31% -0.013 pp | 3.12% -0.646 pp | USD173.21 -27.4% | 13 qtrs — |
| 54 | BNP PARIBAS ARBITRAGE, SNC | 1.37M +596.9K (+76.8%) | 172.92M +59.2M (+52.0%) | 0.31% +0.139 pp | 0.08% +0.018 pp | USD147.73 -14.8% | 51 qtrs — |
| 55 | HSBC HOLDINGS PLC | 1.32M +209.9K (+18.8%) | 166.58M +3.7M (+2.3%) | 0.30% +0.049 pp | 0.08% -0.005 pp | USD148.22 -15.1% | 51 qtrs — |
| 56 | AMERICAN CENTURY COMPANIES INC | 1.30M -94.3K (-6.8%) | 163.32M -40.4M (-19.8%) | 0.30% -0.017 pp | 0.08% -0.022 pp | USD138.70 -9.3% | 51 qtrs — |
| 57 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.29M +252.7K (+24.3%) | 162.55M +10.5M (+6.9%) | 0.29% +0.061 pp | 0.02% +0.001 pp | USD145.90 -13.8% | 52 qtrs — |
| 58 | ENVESTNET ASSET MANAGEMENT INC | 1.25M -607.0K (-32.7%) | 157.36M -114.5M (-42.1%) | 0.29% -0.132 pp | 0.05% -0.032 pp | USD143.28 -12.2% | 51 qtrs — |
| 59 | RHUMBLINE ADVISERS | 1.22M +110.4K (+9.9%) | 154.12M -9.0M (-5.5%) | 0.28% +0.029 pp | 0.12% -0.006 pp | USD82.06 +53.3% | 51 qtrs — |
| 60 | D. E. SHAW & CO., INC. | 1.21M -382.8K (-24.0%) | 152.84M -80.9M (-34.6%) | 0.27% -0.085 pp | 0.08% -0.048 pp | USD152.62 -17.6% | 9 qtrs — |
| 61 | SWISS NATIONAL BANK | 1.21M -69.9K (-5.4%) | 152.67M -35.1M (-18.7%) | 0.27% -0.014 pp | 0.09% -0.018 pp | USD89.34 +40.8% | 51 qtrs — |
| 62 | FUNDSMITH INVESTMENT SERVICES LTD. | 1.21M +30.7K (+2.6%) | 151.79M -20.2M (-11.8%) | 0.28% +0.011 pp | 2.78% +0.096 pp | USD158.85 -20.8% | 19 qtrs — |
| 63 | ABRDN PLC | 1.19M +79.2K (+7.1%) | 149.52M -10.9M (-6.8%) | 0.27% +0.019 pp | 0.23% -0.022 pp | USD158.02 -20.4% | 34 qtrs — |
| 64 | NEUBERGER BERMAN GROUP LLC | 1.18M -458.6K (-27.9%) | 149.09M -91.4M (-38.0%) | 0.27% -0.102 pp | 0.11% -0.065 pp | USD75.45 +66.8% | 51 qtrs — |
| 65 | CITADEL ADVISORS LLC | 1.16M +837.8K (+263.8%) | 145.37M +98.9M (+212.8%) | 0.26% +0.192 pp | 0.02% +0.015 pp | USD135.72 -7.3% | 38 qtrs — |
| 66 | NINETY ONE UK LTD | 1.15M +27.0K (+2.4%) | 144.21M -19.5M (-11.9%) | 0.26% +0.007 pp | 0.31% -0.044 pp | USD180.69 -30.4% | 47 qtrs — |
| 67 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.14M +829.4K (+263.1%) | 144.01M +97.9M (+212.3%) | 0.26% +0.190 pp | 0.51% +0.351 pp | USD131.47 -4.3% | 5 qtrs — |
| 68 | EPOCH INVESTMENT PARTNERS, INC. | 1.13M -33.3K (-2.9%) | 142.63M -28.1M (-16.5%) | 0.26% -0.007 pp | 0.81% -0.128 pp | USD179.22 -29.8% | 40 qtrs — |
| 69 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.10M -37.6K (-3.3%) | 137.93M -28.0M (-16.9%) | 0.25% -0.007 pp | 0.08% -0.015 pp | USD77.18 +63.0% | 51 qtrs — |
| 70 | VONTOBEL HOLDING LTD. | 1.08M -198.7K (-15.6%) | 135.31M -51.1M (-27.4%) | 0.24% -0.044 pp | 0.43% -0.137 pp | USD170.29 -26.1% | 21 qtrs — |
| 71 | LAZARD ASSET MANAGEMENT LLC | 1.07M -1.5M (-58.4%) | 134.96M -242.2M (-64.2%) | 0.24% -0.334 pp | 0.23% -0.279 pp | USD88.76 +41.8% | 51 qtrs — |
| 72 | SARASIN & PARTNERS LLP | 1.07M -579.4K (-35.1%) | 134.70M -101.3M (-42.9%) | 0.24% -0.129 pp | 1.40% -0.918 pp | USD163.92 -23.2% | 30 qtrs — |
| 73 | LAZARD FRERES GESTION S.A.S. | 1.06M -58.6K (-5.3%) | 132.99M -30.2M (-18.5%) | 0.24% -0.012 pp | 2.40% -0.711 pp | USD193.12 -34.8% | 21 qtrs — |
| 74 | VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 1.05M +918.8K (+680.1%) | 132.60M +112.8M (+570.8%) | 0.24% +0.207 pp | 1.14% +0.959 pp | USD133.45 -5.7% | 9 qtrs — |
| 75 | BARCLAYS PLC | 1.04M -492.6K (-32.2%) | 130.74M -168.5M (-56.3%) | 0.24% -0.107 pp | 0.03% -0.045 pp | USD168.56 -25.4% | 51 qtrs — |
| 76 | CITIGROUP INC | 1.03M +362.1K (+53.9%) | 130.16M +31.8M (+32.3%) | 0.23% +0.082 pp | 0.06% +0.014 pp | USD145.08 -13.3% | 52 qtrs — |
| 77 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 1.03M -620.9K (-37.5%) | 130.04M -112.0M (-46.3%) | 0.23% -0.139 pp | 0.07% -0.071 pp | USD99.64 +26.3% | 52 qtrs — |
| 78 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 973.4K +805.9K (+481.4%) | 122.47M +98.0M (+399.9%) | 0.22% +0.185 pp | 0.01% +0.011 pp | USD130.89 -3.9% | 27 qtrs — |
| 79 | BLAIR WILLIAM & CO/IL | 970.0K -393.2K (-28.8%) | 122.04M -77.4M (-38.8%) | 0.22% -0.085 pp | 0.33% -0.203 pp | USD64.47 +95.2% | 51 qtrs — |
| 80 | AVIVA PLC | 934.0K -57.2K (-5.8%) | 117.52M -27.5M (-19.0%) | 0.21% -0.012 pp | 0.20% -0.065 pp | USD149.07 -15.6% | 48 qtrs — |
| 81 | RAYMOND JAMES FINANCIAL INC | 920.5K -170.0K (-15.6%) | 115.82M -43.7M (-27.4%) | 0.21% -0.037 pp | 0.04% -0.015 pp | USD162.96 -22.8% | 5 qtrs — |
| 82 | CCLA INVESTMENT MANAGEMENT | 885.4K -13.2K (-1.5%) | 111.39M -20.0M (-15.2%) | 0.20% -0.002 pp | 1.79% -0.315 pp | USD160.67 -21.7% | 14 qtrs — |
| 83 | ALECTA TJANSTEPENSION OMSESIDIGT | 882.2K +— (+0.0%) | 110.99M -18.0M (-14.0%) | 0.20% +0.001 pp | 0.49% -0.088 pp | USD158.69 -20.7% | 5 qtrs — |
| 84 | KING LUTHER CAPITAL MANAGEMENT CORP | 850.9K -193.5K (-18.5%) | 107.06M -45.8M (-29.9%) | 0.19% -0.043 pp | 0.44% -0.194 pp | USD68.62 +83.4% | 41 qtrs — |
| 85 | SCHARF INVESTMENTS, LLC | 818.9K +324.7K (+65.7%) | 103.03M +30.7M (+42.5%) | 0.18% +0.074 pp | 2.77% +0.950 pp | USD138.19 -9.0% | 2 qtrs — |
| 86 | SQUAREPOINT OPS LLC | 807.2K +68.7K (+9.3%) | 101.57M -6.5M (-6.0%) | 0.18% +0.016 pp | 0.11% -0.001 pp | USD154.41 -18.5% | 31 qtrs — |
| 87 | AQR CAPITAL MANAGEMENT LLC | 802.7K -735.9K (-47.8%) | 101.00M -120.9M (-54.5%) | 0.18% -0.165 pp | 0.05% -0.089 pp | USD160.03 -21.4% | 51 qtrs — |
| 88 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 799.1K +220.5K (+38.1%) | 100.54M +16.2M (+19.2%) | 0.18% +0.052 pp | 0.12% -0.103 pp | USD150.03 -16.1% | 51 qtrs — |
| 89 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 793.5K +290.5K (+57.8%) | 100.20M +26.6M (+36.2%) | 0.18% +0.066 pp | 0.16% +0.041 pp | USD149.42 -15.8% | 5 qtrs — |
| 90 | MAN GROUP PLC | 786.8K +9.3K (+1.2%) | 98.99M -14.8M (-13.0%) | 0.18% +0.003 pp | 0.17% -0.030 pp | USD159.30 -21.0% | 32 qtrs — |
| 91 | CI PRIVATE WEALTH, LLC | 760.7K -283.2K (-27.1%) | 95.84M -56.9M (-37.3%) | 0.17% -0.063 pp | 0.13% -0.112 pp | USD167.87 -25.0% | 13 qtrs — |
| 92 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 723.5K -3.9K (-0.5%) | 91.03M -15.4M (-14.5%) | 0.16% 0.000 pp | 0.09% -0.018 pp | USD61.87 +103.4% | 52 qtrs — |
| 93 | NATIONAL PENSION SERVICE | 715.2K -675.2K (-48.6%) | 89.99M -113.5M (-55.8%) | 0.16% -0.151 pp | 0.07% -0.091 pp | USD125.65 +0.1% | 46 qtrs — |
| 94 | TANDEM INVESTMENT ADVISORS, INC. | 707.8K -82.5K (-10.4%) | 89.05M -26.6M (-23.0%) | 0.16% -0.018 pp | 3.32% -0.631 pp | USD159.87 -21.3% | 5 qtrs — |
| 95 | CANADA PENSION PLAN INVESTMENT BOARD | 674.8K +31.8K (+4.9%) | 84.91M -9.2M (-9.8%) | 0.15% +0.010 pp | 0.06% -0.009 pp | USD161.93 -22.3% | 52 qtrs — |
| 96 | SEI INVESTMENTS CO | 673.0K -9.0K (-1.3%) | 84.67M -15.1M (-15.1%) | 0.15% -0.002 pp | 0.08% -0.024 pp | USD146.07 -13.9% | 45 qtrs — |
| 97 | BANK JULIUS BAER & CO. LTD, ZURICH | 659.2K -13.6K (-2.0%) | 82.95M -15.5M (-15.7%) | 0.15% -0.002 pp | 0.23% -0.049 pp | USD180.87 -30.4% | 24 qtrs — |
| 98 | ALLIANZ ASSET MANAGEMENT GMBH | 633.9K +14.4K (+2.3%) | 79.75M -10.9M (-12.0%) | 0.14% +0.004 pp | 0.08% -0.021 pp | USD136.30 -7.7% | 51 qtrs — |
| 99 | FAYEZ SAROFIM & CO | 607.6K -640.6K (-51.3%) | 76.45M -106.2M (-58.1%) | 0.14% -0.142 pp | 0.18% -0.240 pp | USD145.12 -13.3% | 49 qtrs — |
| 100 | J. STERN & CO. LLP | 24.07M +23.9M (+12,431.2%) | 24.07M -4.0M (-14.4%) | 5.43% +5.391 pp | 2.05% -0.075 pp | USD126.17 -0.3% | 9 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
4.50
Bullish
Ratio by volume
3.00
Bullish
Buys
9
Sells
2
Shares acquired
5.3K
Shares disposed
334.92
Cash buys
—
Cash sales
—
Net activity
+4,939
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Esch Kevin | Officer | M-Exempt | A | Common Stock | 259 | 0.00 | — | 653 | D | ↗ |
| 2026-04-10 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 231 | 0.00 | — | 2,105 | D | ↗ |
| 2026-04-10 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 2,777 | 0.00 | — | 65,579 | D | ↗ |
| 2026-04-10 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 551 | 0.00 | — | 30,632 | D | ↗ |
| 2026-04-10 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 874 | 0.00 | — | 9,792 | D | ↗ |
| 2026-04-10 | Ferran Astorga Jeannette | Officer | A-Award | A | Phantom Stock Unit | 5 | 0.00 | — | 2,251 | D | ↗ |
| 2026-04-10 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 551 | 0.00 | — | 1,798 | D | ↗ |
| 2026-04-10 | Esch Kevin | Officer | A-Award | A | Phantom Stock Unit | 1 | 0.00 | — | 498 | D | ↗ |
| 2026-04-10 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 26 | 0.00 | — | 6,036 | D | ↗ |
| 2026-03-31 | Sarbaugh Keith | Officer | M-Exempt | A | Common Stock | 1,528 | 0.00 | — | 3,870 | D | ↗ |
| 2026-03-27 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 627 | 0.00 | — | 1,874 | D | ↗ |
| 2026-03-27 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 4,391 | 0.00 | — | 62,802 | D | ↗ |
| 2026-03-27 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 1,266 | 0.00 | — | 30,082 | D | ↗ |
| 2026-03-27 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 2,115 | 0.00 | — | 8,918 | D | ↗ |
| 2026-03-27 | Ferran Astorga Jeannette | Officer | A-Award | A | Phantom Stock Unit | 593 | 0.00 | — | 2,246 | D | ↗ |
| 2026-03-27 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 669 | 0.00 | — | 1,247 | D | ↗ |
| 2026-03-27 | Esch Kevin | Officer | A-Award | A | Phantom Stock Unit | 220 | 0.00 | — | 497 | D | ↗ |
| 2026-03-27 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 642 | 0.00 | — | 6,010 | D | ↗ |
| 2026-03-19 | Stetter Mark | Director | A-Award | A | Phantom Stock Unit | 216 | 0.00 | — | 216 | D | ↗ |
| 2026-03-09 | Norden Gregory | Director | G-Gift | D | Common Stock | 1,213 | 0.00 | — | 0 | D | ↗ |
| 2026-02-19 | Sarbaugh Keith | Officer | M-Exempt | A | Common Stock | 386 | 0.00 | — | 2,496 | D | ↗ |
| 2026-02-19 | Sanjay Khosla | Director | A-Award | A | Deferred Stock Unit | 1,619 | 0.00 | — | 11,621 | D | ↗ |
| 2026-02-19 | Reed Willie M | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 12,864 | D | ↗ |
| 2026-02-19 | PECK KRISTIN C | Director / Officer | M-Exempt | D | Restricted Stock Unit | 7,355 | 0.00 | — | 14,708 | D | ↗ |
| 2026-02-19 | PARENT LOUISE M | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 16,879 | D | ↗ |
| 2026-02-19 | Norden Gregory | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 1,619 | D | ↗ |
| 2026-02-19 | MCCALLISTER MICHAEL B | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 1,622 | D | ↗ |
| 2026-02-19 | Leatherberry Antoinette Renee | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 5,686 | D | ↗ |
| 2026-02-19 | Lagano Roxanne | Officer | M-Exempt | D | Restricted Stock Unit | 750 | 0.00 | — | 1,500 | D | ↗ |
| 2026-02-19 | Joseph Wetteny | Officer | M-Exempt | A | Common Stock | 2,050 | 0.00 | — | 22,816 | D | ↗ |
| 2026-02-19 | Hattersley Gavin | Director | M-Exempt | D | Restricted Stock Unit | 1,619 | 0.00 | — | 0 | D | ↗ |
| 2026-02-19 | Ferran Astorga Jeannette | Officer | F-InKind | D | Common Stock | 190 | 127.28 | 24.2K | 1,684 | D | ↗ |
| 2026-02-19 | FULLER JULIE | Officer | M-Exempt | D | Restricted Stock Unit | 750 | 0.00 | — | 1,500 | D | ↗ |
| 2026-02-19 | Esch Kevin | Officer | F-InKind | D | Common Stock | 35 | 127.28 | 4.5K | 394 | D | ↗ |
| 2026-02-19 | Driscoll Rimma | Officer | M-Exempt | A | Common Stock | 454 | 0.00 | — | 5,894 | D | ↗ |
| 2026-02-19 | DAMELIO FRANK A | Director | A-Award | A | Deferred Stock Unit | 1,619 | 0.00 | — | 11,621 | D | ↗ |
| 2026-02-19 | Broadhurst Vanessa | Director | J-Other | D | Common Stock | 517 | 127.28 | 65.8K | 3,920 | D | ↗ |
| 2026-02-19 | Brannan Jamie | Officer | M-Exempt | D | Restricted Stock Unit | 1,204 | 0.00 | — | 2,410 | D | ↗ |
| 2026-02-19 | Bisaro Paul | Director | M-Exempt | A | Common Stock | 1,619 | 0.00 | — | 25,862 | D | ↗ |
| 2026-02-19 | Ashton Nicholas | Officer | M-Exempt | D | Restricted Stock Unit | 750 | 0.00 | — | 1,500 | D | ↗ |
| 2026-02-18 | Tilenius Stephanie | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Stetter Mark | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Sarbaugh Keith | Officer | A-Award | A | Stock Option | 10,581 | 129.13 | 1.37M | 10,581 | D | ↗ |
| 2026-02-18 | Sanjay Khosla | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Reed Willie M | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | PECK KRISTIN C | Director / Officer | A-Award | A | Stock Option | 111,060 | 129.13 | 14.34M | 111,060 | D | ↗ |
| 2026-02-18 | PARENT LOUISE M | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Norden Gregory | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | MCCALLISTER MICHAEL B | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Leatherberry Antoinette Renee | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Lagano Roxanne | Officer | A-Award | A | Stock Option | 14,499 | 129.13 | 1.87M | 14,499 | D | ↗ |
| 2026-02-18 | Joseph Wetteny | Officer | A-Award | A | Stock Option | 34,045 | 129.13 | 4.40M | 34,045 | D | ↗ |
| 2026-02-18 | Hattersley Gavin | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Ferran Astorga Jeannette | Officer | A-Award | A | Stock Option | 8,693 | 129.13 | 1.12M | 8,693 | D | ↗ |
| 2026-02-18 | FULLER JULIE | Officer | A-Award | A | Stock Option | 14,345 | 129.13 | 1.85M | 14,345 | D | ↗ |
| 2026-02-18 | Esch Kevin | Officer | A-Award | A | Stock Option | 15,931 | 129.13 | 2.06M | 15,931 | D | ↗ |
| 2026-02-18 | Driscoll Rimma | Officer | A-Award | A | Stock Option | 9,191 | 129.13 | 1.19M | 9,191 | D | ↗ |
| 2026-02-18 | DAMELIO FRANK A | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Broadhurst Vanessa | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Brannan Jamie | Officer | A-Award | A | Stock Option | 21,361 | 129.13 | 2.76M | 21,361 | D | ↗ |
| 2026-02-18 | Bisaro Paul | Director | A-Award | A | Restricted Stock Unit | 1,936 | 0.00 | — | 1,936 | D | ↗ |
| 2026-02-18 | Ashton Nicholas | Officer | A-Award | A | Stock Option | 16,413 | 129.13 | 2.12M | 16,413 | D | ↗ |
| 2026-02-17 | PECK KRISTIN C | Director / Officer | S-Sale | D | Common Stock | 9,200 | 126.46 | 1.16M | 112,137 | D | ↗ |
| 2026-02-08 | PECK KRISTIN C | Director / Officer | F-InKind | D | Common Stock | 2,722 | 127.42 | 346.8K | 101,337 | D | ↗ |
| 2026-02-08 | Lagano Roxanne | Officer | M-Exempt | D | Restricted Stock Unit | 606 | 0.00 | — | 0 | D | ↗ |
| 2026-02-08 | Joseph Wetteny | Officer | F-InKind | D | Common Stock | 483 | 127.42 | 61.5K | 20,766 | D | ↗ |
| 2026-02-08 | Ferran Astorga Jeannette | Officer | M-Exempt | D | Restricted Stock Unit | 218 | 0.00 | — | 0 | D | ↗ |
| 2026-02-08 | Esch Kevin | Officer | M-Exempt | D | Restricted Stock Unit | 51 | 0.00 | — | 0 | D | ↗ |
| 2026-02-08 | Driscoll Rimma | Officer | M-Exempt | D | Restricted Stock Unit | 193 | 0.00 | — | 0 | D | ↗ |
| 2026-02-08 | Brannan Jamie | Officer | M-Exempt | D | Restricted Stock Unit | 380 | 0.00 | — | 0 | D | ↗ |
| 2026-02-08 | Ashton Nicholas | Officer | M-Exempt | A | Common Stock | 398 | 0.00 | — | 1,673 | D | ↗ |
| 2026-02-06 | Sarbaugh Keith | Officer | M-Exempt | A | Common Stock | 119 | 0.00 | — | 2,158 | D | ↗ |
| 2026-02-06 | PECK KRISTIN C | Director / Officer | M-Exempt | A | Common Stock | 5,555 | 0.00 | — | 99,749 | D | ↗ |
| 2026-02-06 | Lagano Roxanne | Officer | M-Exempt | D | Restricted Stock Unit | 545 | 0.00 | — | 545 | D | ↗ |
| 2026-02-06 | Joseph Wetteny | Officer | M-Exempt | A | Common Stock | 1,388 | 0.00 | — | 20,355 | D | ↗ |
| 2026-02-06 | Ferran Astorga Jeannette | Officer | M-Exempt | A | Common Stock | 206 | 0.00 | — | 1,414 | D | ↗ |
| 2026-02-06 | Esch Kevin | Officer | M-Exempt | A | Common Stock | 43 | 0.00 | — | 310 | D | ↗ |
| 2026-02-06 | Driscoll Rimma | Officer | M-Exempt | A | Common Stock | 222 | 0.00 | — | 5,414 | D | ↗ |
| 2026-02-06 | Brannan Jamie | Officer | M-Exempt | D | Restricted Stock Unit | 529 | 0.00 | — | 529 | D | ↗ |
| 2026-02-06 | Ashton Nicholas | Officer | F-InKind | D | Common Stock | 200 | 127.42 | 25.5K | 1,275 | D | ↗ |
| 2026-01-09 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 150 | 0.00 | — | 1,248 | D | ↗ |
| 2026-01-09 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 367 | 0.00 | — | 58,411 | D | ↗ |
| 2026-01-09 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 190 | 0.00 | — | 28,815 | D | ↗ |
| 2026-01-09 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 218 | 0.00 | — | 6,804 | D | ↗ |
| 2026-01-09 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 190 | 0.00 | — | 578 | D | ↗ |
| 2026-01-09 | Esch Kevin | Officer | A-Award | A | Phantom Stock Unit | 101 | 0.00 | — | 277 | D | ↗ |
| 2026-01-09 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 141 | 0.00 | — | 5,368 | D | ↗ |
| 2026-01-01 | Esch Kevin | Officer | — | — | Common Stock | 0 | 0.00 | — | 267 | D | ↗ |
| 2025-12-01 | Tilenius Stephanie | Director | A-Award | A | Restricted Stock Unit | 1,964 | 0.00 | — | 1,964 | D | ↗ |
| 2025-10-10 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 159 | 0.00 | — | 1,098 | D | ↗ |
| 2025-10-10 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 205 | 0.00 | — | 10,990 | D | ↗ |
| 2025-10-10 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 389 | 0.00 | — | 58,044 | D | ↗ |
| 2025-10-10 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 202 | 0.00 | — | 28,625 | D | ↗ |
| 2025-10-10 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 231 | 0.00 | — | 6,586 | D | ↗ |
| 2025-10-10 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 202 | 0.00 | — | 388 | D | ↗ |
| 2025-10-10 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 150 | 0.00 | — | 5,226 | D | ↗ |
| 2025-09-30 | FULLER JULIE | Officer | M-Exempt | A | Common Stock | 784 | 0.00 | — | 872 | D | ↗ |
| 2025-09-15 | Lagano Roxanne | Officer | G-Gift | D | Common Stock | 700 | 0.00 | — | 14,429 | D | ↗ |
| 2025-07-25 | Broadhurst Vanessa | Director | J-Other | D | Common Stock | 451 | 152.12 | 68.6K | 2,818 | D | ↗ |
| 2025-07-11 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 125 | 0.00 | — | 940 | D | ↗ |
| 2025-07-11 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 161 | 0.00 | — | 10,785 | D | ↗ |
| 2025-07-11 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 306 | 0.00 | — | 57,655 | D | ↗ |
| 2025-07-11 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 159 | 0.00 | — | 28,423 | D | ↗ |
| 2025-07-11 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 181 | 0.00 | — | 6,355 | D | ↗ |
| 2025-07-11 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 159 | 0.00 | — | 186 | D | ↗ |
| 2025-07-11 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 118 | 0.00 | — | 5,077 | D | ↗ |
| 2025-06-03 | Lagano Roxanne | Officer | S-Sale | D | Common Stock | 652 | 170.00 | 110.8K | 15,129 | D | ↗ |
| 2025-05-21 | Stetter Mark | Director | — | — | No securities beneficially held | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-05-21 | SCULLY ROBERT W | Director | M-Exempt | A | Common Stock | 5,905 | 0.00 | — | 21,489 | D | ↗ |
| 2025-05-20 | MCCALLISTER MICHAEL B | Director | G-Gift | D | Common Stock | 1,830 | 0.00 | — | 3 | D | ↗ |
| 2025-04-04 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 131 | 0.00 | — | 815 | D | ↗ |
| 2025-04-04 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 582 | 0.00 | — | 10,624 | D | ↗ |
| 2025-04-04 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 2,760 | 0.00 | — | 57,348 | D | ↗ |
| 2025-04-04 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 467 | 0.00 | — | 28,264 | D | ↗ |
| 2025-04-04 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 866 | 0.00 | — | 6,174 | D | ↗ |
| 2025-04-04 | FULLER JULIE | Officer | A-Award | A | Phantom Stock Unit | 27 | 0.00 | — | 27 | D | ↗ |
| 2025-04-04 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 20 | 0.00 | — | 4,959 | D | ↗ |
| 2025-04-01 | Hattersley Gavin | Director | M-Exempt | A | Common Stock | 1,451 | 0.00 | — | 2,216 | D | ↗ |
| 2025-03-31 | Sarbaugh Keith | Officer | M-Exempt | A | Common Stock | 1,506 | 0.00 | — | 2,555 | D | ↗ |
| 2025-03-28 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 353 | 0.00 | — | 684 | D | ↗ |
| 2025-03-28 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 799 | 0.00 | — | 10,042 | D | ↗ |
| 2025-03-28 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 2,874 | 0.00 | — | 54,588 | D | ↗ |
| 2025-03-28 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 895 | 0.00 | — | 27,797 | D | ↗ |
| 2025-03-28 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 1,412 | 0.00 | — | 5,307 | D | ↗ |
| 2025-03-28 | Ferran Astorga Jeannette | Officer | A-Award | A | Phantom Stock Unit | 345 | 0.00 | — | 1,653 | D | ↗ |
| 2025-03-28 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 382 | 0.00 | — | 4,938 | D | ↗ |
| 2025-03-11 | Reed Willie M | Director | S-Sale | D | Common Stock | 1,210 | 166.14 | 201.0K | 11,245 | D | ↗ |
| 2025-03-10 | Lagano Roxanne | Officer | S-Sale | D | Common Stock | 326 | 170.00 | 55.4K | 15,781 | D | ↗ |
| 2025-02-19 | Sarbaugh Keith | Officer | A-Award | A | Restricted Stock Unit | 1,143 | 0.00 | — | 1,143 | D | ↗ |
| 2025-02-19 | Sanjay Khosla | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | SCULLY ROBERT W | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Reed Willie M | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Polzer Robert J | Officer | A-Award | A | Restricted Stock Unit | 3,546 | 0.00 | — | 3,546 | D | ↗ |
| 2025-02-19 | PECK KRISTIN C | Director / Officer | M-Exempt | A | Common Stock | 382 | 46.09 | 17.6K | 94,576 | D | ↗ |
| 2025-02-19 | PARENT LOUISE M | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Norden Gregory | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | MCCALLISTER MICHAEL B | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Leatherberry Antoinette Renee | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Lagano Roxanne | Officer | A-Award | A | Restricted Stock Unit | 2,218 | 0.00 | — | 2,218 | D | ↗ |
| 2025-02-19 | Joseph Wetteny | Officer | A-Award | A | Restricted Stock Unit | 6,064 | 0.00 | — | 6,064 | D | ↗ |
| 2025-02-19 | Hattersley Gavin | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Ferran Astorga Jeannette | Officer | A-Award | A | Restricted Stock Unit | 1,276 | 0.00 | — | 1,276 | D | ↗ |
| 2025-02-19 | FULLER JULIE | Officer | A-Award | A | Restricted Stock Unit | 2,218 | 0.00 | — | 2,218 | D | ↗ |
| 2025-02-19 | Driscoll Rimma | Officer | A-Award | A | Restricted Stock Unit | 1,343 | 0.00 | — | 1,343 | D | ↗ |
| 2025-02-19 | DAMELIO FRANK A | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Broadhurst Vanessa | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Brannan Jamie | Officer | A-Award | A | Stock Option | 13,877 | 156.64 | 2.17M | 13,877 | D | ↗ |
| 2025-02-19 | BISARO PAUL | Director | A-Award | A | Restricted Stock Unit | 1,596 | 0.00 | — | 1,596 | D | ↗ |
| 2025-02-19 | Ashton Nicholas | Officer | A-Award | A | Restricted Stock Unit | 2,218 | 0.00 | — | 2,218 | D | ↗ |
| 2025-02-14 | Norden Gregory | Director | G-Gift | D | Common Stock | 1,843 | 0.00 | — | 0 | D | ↗ |
| 2025-02-11 | Lagano Roxanne | Officer | S-Sale | D | Common Stock | 326 | 171.18 | 55.8K | 16,107 | D | ↗ |
| 2025-02-08 | Sanjay Khosla | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | SCULLY ROBERT W | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | Reed Willie M | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | Polzer Robert J | Officer | F-InKind | D | Common Stock | 190 | 171.43 | 32.6K | 4,135 | D | ↗ |
| 2025-02-08 | PECK KRISTIN C | Director / Officer | M-Exempt | A | Common Stock | 14,298 | 0.00 | — | 100,369 | D | ↗ |
| 2025-02-08 | PARENT LOUISE M | Director | J-Other | D | Common Stock | 466 | 171.43 | 79.9K | 15,260 | D | ↗ |
| 2025-02-08 | Norden Gregory | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | MCCALLISTER MICHAEL B | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | Leatherberry Antoinette Renee | Director | M-Exempt | D | Restricted Stock Unit | 1,225 | 0.00 | — | 0 | D | ↗ |
| 2025-02-08 | Lagano Roxanne | Officer | F-InKind | D | Common Stock | 226 | 171.43 | 38.7K | 15,493 | D | ↗ |
| 2025-02-08 | Joseph Wetteny | Officer | M-Exempt | A | Common Stock | 2,936 | 0.00 | — | 20,001 | D | ↗ |
| 2025-02-08 | Ferran Astorga Jeannette | Officer | M-Exempt | A | Common Stock | 214 | 0.00 | — | 1,008 | D | ↗ |
| 2025-02-08 | Driscoll Rimma | Officer | M-Exempt | A | Common Stock | 254 | 0.00 | — | 5,294 | D | ↗ |
| 2025-02-08 | DAMELIO FRANK A | Director | A-Award | A | Deferred Stock Unit | 1,225 | 0.00 | — | 9,857 | D | ↗ |
| 2025-02-08 | Brannan Jamie | Officer | M-Exempt | D | Restricted Stock Unit | 374 | 0.00 | — | 375 | D | ↗ |
| 2025-02-08 | BISARO PAUL | Director | M-Exempt | A | Common Stock | 1,225 | 0.00 | — | 24,243 | D | ↗ |
| 2025-02-08 | Ashton Nicholas | Officer | M-Exempt | A | Common Stock | 170 | 0.00 | — | 1,183 | D | ↗ |
| 2025-02-06 | Sarbaugh Keith | Officer | F-InKind | D | Common Stock | 47 | 174.12 | 8.2K | 1,049 | D | ↗ |
| 2025-02-06 | Sanjay Khosla | Director | M-Exempt | D | Restricted Stock Unit | 1,236 | 0.00 | — | 0 | D | ↗ |
| 2025-02-06 | SCULLY ROBERT W | Director | M-Exempt | D | Restricted Stock Unit | 1,236 | 0.00 | — | 0 | D | ↗ |
| 2025-02-06 | Reed Willie M | Director | M-Exempt | D | Restricted Stock Unit | 1,236 | 0.00 | — | 0 | D | ↗ |
| 2025-02-06 | Polzer Robert J | Officer | F-InKind | D | Common Stock | 209 | 174.12 | 36.4K | 3,662 | D | ↗ |
| 2025-02-06 | PECK KRISTIN C | Director / Officer | M-Exempt | A | Common Stock | 5,475 | 0.00 | — | 84,841 | D | ↗ |
| 2025-02-06 | PARENT LOUISE M | Director | M-Exempt | D | Restricted Stock Unit | 1,236 | 0.00 | — | 0 | D | ↗ |
| 2025-02-06 | Norden Gregory | Director | M-Exempt | A | Common Stock | 1,236 | 0.00 | — | 1,236 | D | ↗ |
| 2025-02-06 | MCCALLISTER MICHAEL B | Director | J-Other | D | Common Stock | 316 | 174.12 | 55.0K | 921 | D | ↗ |
| 2025-02-06 | Leatherberry Antoinette Renee | Director | M-Exempt | A | Common Stock | 1,236 | 0.00 | — | 3,460 | D | ↗ |
| 2025-02-06 | Lagano Roxanne | Officer | M-Exempt | D | Restricted Stock Unit | 536 | 0.00 | — | 1,074 | D | ↗ |
| 2025-02-06 | Joseph Wetteny | Officer | M-Exempt | A | Common Stock | 1,368 | 0.00 | — | 16,649 | D | ↗ |
| 2025-02-06 | Ferran Astorga Jeannette | Officer | F-InKind | D | Common Stock | 82 | 174.12 | 14.3K | 794 | D | ↗ |
| 2025-02-06 | Driscoll Rimma | Officer | M-Exempt | A | Common Stock | 219 | 0.00 | — | 5,014 | D | ↗ |
| 2025-02-06 | DAMELIO FRANK A | Director | A-Award | A | Deferred Stock Unit | 1,236 | 0.00 | — | 8,632 | D | ↗ |
| 2025-02-06 | Broadhurst Vanessa | Director | M-Exempt | A | Common Stock | 1,236 | 0.00 | — | 2,252 | D | ↗ |
| 2025-02-06 | Brannan Jamie | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 2,067 | D | ↗ |
| 2025-02-06 | BISARO PAUL | Director | M-Exempt | A | Common Stock | 1,236 | 0.00 | — | 23,018 | D | ↗ |
| 2025-02-06 | Ashton Nicholas | Officer | M-Exempt | A | Common Stock | 375 | 0.00 | — | 1,021 | D | ↗ |
| 2025-01-10 | Sarbaugh Keith | Officer | A-Award | A | Phantom Stock Unit | 105 | 0.00 | — | 331 | D | ↗ |
| 2025-01-10 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 144 | 0.00 | — | 9,243 | D | ↗ |
| 2025-01-10 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 283 | 0.00 | — | 51,714 | D | ↗ |
| 2025-01-10 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 141 | 0.00 | — | 26,903 | D | ↗ |
| 2025-01-10 | Joseph Wetteny | Officer | A-Award | A | Phantom Stock Unit | 163 | 0.00 | — | 3,895 | D | ↗ |
| 2025-01-10 | Ferran Astorga Jeannette | Officer | A-Award | A | Phantom Stock Unit | 92 | 0.00 | — | 1,307 | D | ↗ |
| 2025-01-10 | Driscoll Rimma | Officer | A-Award | A | Phantom Stock Unit | 98 | 0.00 | — | 4,557 | D | ↗ |
| 2024-11-25 | Polzer Robert J | Officer | M-Exempt | A | Common Stock | 1,057 | 160.62 | 169.8K | 4,306 | D | ↗ |
| 2024-11-11 | Sarbaugh Keith | Officer | — | — | Common Stock | 0 | 0.00 | — | 979 | D | ↗ |
| 2024-10-04 | Polzer Robert J | Officer | A-Award | A | Phantom Stock Unit | 145 | 0.00 | — | 9,100 | D | ↗ |
| 2024-10-04 | PECK KRISTIN C | Director / Officer | A-Award | A | Phantom Stock Unit | 287 | 0.00 | — | 51,431 | D | ↗ |
| 2024-10-04 | Mamilli Wafaa | Officer | A-Award | A | Phantom Stock Unit | 143 | 0.00 | — | 8,035 | D | ↗ |
| 2024-10-04 | Lagano Roxanne | Officer | A-Award | A | Phantom Stock Unit | 138 | 0.00 | — | 26,762 | D | ↗ |
Executive team
Top executives
EBIT / Employee
259.6K
Shares Outstanding
422.13M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Kristin C. Peck Chief Executive Officer | 1.30M | — | 9.56M | 3.19M | 2.73M | 426.9K | 17.21M | 74.10% | ↗ |
| 2 | 2024 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 750.0K | — | 2.39M | 796.9K | 997.5K | 154.6K | 5.09M | 62.63% | ↗ |
| 3 | 2024 | Heidi C. Chen Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 346.8K | — | 1.06M | 353.7K | 310.7K | 1.55M | 3.62M | 39.07% | ↗ |
| 4 | 2024 | Jamie Brannan EVP and Chief Commercial Officer | 659.4K | — | 910.9K | 303.7K | 752.1K | 398.5K | 3.02M | 40.16% | ↗ |
| 5 | 2024 | Robert J. Polzer EVP and President of Research and Development | 660.0K | — | 1.09M | 362.5K | 739.2K | 123.9K | 2.97M | 48.77% | ↗ |
| 6 | 2024 | Wafaa Mamilli Former EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 650.0K | — | 1.03M | 345.0K | 623.7K | 131.0K | 2.78M | 49.55% | ↗ |
| 7 | 2024 | Roxanne Lagano EVP, General Counsel and Corporate Secretary | 620.8K | — | 937.2K | 312.5K | 627.4K | 117.3K | 2.62M | 47.79% | ↗ |
| 8 | 2023 | Kristin C. Peck Chief Executive Officer | 1.20M | — | 8.77M | 2.92M | 2.11M | 232.0K | 15.24M | 76.78% | ↗ |
| 9 | 2023 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 725.0K | — | 1.99M | 662.5K | 763.4K | 109.7K | 4.25M | 62.38% | ↗ |
| 10 | 2023 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 650.0K | — | 997.3K | 332.5K | 608.4K | 98.3K | 2.69M | 49.50% | ↗ |
| 11 | 2023 | Wafaa Mamilli Former EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 650.0K | — | 997.3K | 332.5K | 608.4K | 98.3K | 2.69M | 49.50% | ↗ |
| 12 | 2023 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 635.0K | — | 1.02M | 341.2K | 513.4K | 91.9K | 2.60M | 52.39% | ↗ |
| 13 | 2023 | Heidi C. Chen Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 635.0K | — | 1.02M | 341.2K | 513.4K | 91.9K | 2.60M | 52.39% | ↗ |
| 14 | 2023 | Robert J. Polzer EVP and President of Research and Development | 575.0K | — | 948.5K | 316.2K | 538.2K | 62.5K | 2.44M | 51.82% | ↗ |
| 15 | 2022 | Kristin C. Peck Chief Executive Officer | 1.20M | — | 8.40M | 2.80M | 1.31M | 289.7K | 14.00M | 79.98% | ↗ |
| 16 | 2022 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725.0K | — | 2.08M | 693.1K | — | 136.4K | 3.63M | 76.29% | ↗ |
| 17 | 2022 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 700.0K | — | 1.72M | 575.0K | 459.9K | 95.4K | 3.56M | 64.69% | ↗ |
| 18 | 2022 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615.0K | — | 993.4K | 331.2K | 314.3K | 106.7K | 2.36M | 56.12% | ↗ |
| 19 | 2022 | Heidi C. Chen Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615.0K | — | 993.4K | 331.2K | 314.3K | 106.7K | 2.36M | 56.12% | ↗ |
| 20 | 2022 | Wafaa Mamilli Former EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 608.3K | — | 824.9K | 275.0K | 355.3K | 114.6K | 2.18M | 50.50% | ↗ |
| 21 | 2022 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 608.3K | — | 824.9K | 275.0K | 355.3K | 114.6K | 2.18M | 50.50% | ↗ |
| 22 | 2021 | Kristin C. Peck Chief Executive Officer | 1.20M | — | 6.93M | 2.31M | 2.34M | 318.7K | 13.10M | 70.54% | ↗ |
| 23 | 2021 | Wetteny Joseph Executive Vice President (“EVP”) and Chief Financial Officer | 393.8K | 2.00M | 5.10M | — | 472.5K | 43.6K | 8.01M | 63.67% | ↗ |
| 24 | 2021 | Wetteny Joseph EVP and CFO since June 1, 2021 | 393.8K | 2.00M | 5.10M | — | 472.5K | 43.6K | 8.01M | 63.67% | ↗ |
| 25 | 2021 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 725.0K | — | 2.08M | 693.1K | 1.02M | 159.3K | 4.67M | 59.31% | ↗ |
| 26 | 2021 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725.0K | — | 2.08M | 693.1K | 1.02M | 159.3K | 4.67M | 59.31% | ↗ |
| 27 | 2021 | Catherine A. Knupp EVP, President of Research and Development | 710.0K | — | 1.37M | 456.2K | 852.0K | 168.4K | 3.56M | 51.33% | ↗ |
| 28 | 2021 | Roman Trawicki EVP, President of Global Manufacturing and Supply | 675.0K | — | 1.05M | 350.0K | 842.4K | 401.4K | 3.32M | 42.18% | ↗ |
| 29 | 2021 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | 615.0K | — | 993.5K | 331.2K | 645.8K | 133.9K | 2.72M | 48.72% | ↗ |
| 30 | 2021 | Heidi C. Chen EVP, General Counsel and Corporate Secretary; Lead of Human Health Diagnostics | 615.0K | — | 993.5K | 331.2K | 645.8K | 133.9K | 2.72M | 48.72% | ↗ |
| 31 | 2021 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 600.0K | — | 712.2K | 237.5K | 727.2K | 195.8K | 2.47M | 38.41% | ↗ |
| 32 | 2020 | Kristin C. Peck Chief Executive Officer | 1.10M | — | 5.68M | 1.89M | 1.53M | 163.3K | 10.37M | 73.06% | ↗ |
| 33 | 2020 | Wafaa Mamilli EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health | 556.5K | 1.25M | 974.8K | 575.0K | 559.7K | 237.3K | 4.15M | 37.32% | ↗ |
| 34 | 2020 | Glenn C. David EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices | 725.0K | — | 1.91M | 637.5K | 672.8K | 130.4K | 4.08M | 62.53% | ↗ |
| 35 | 2020 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 725.0K | — | 1.91M | 637.5K | 672.8K | 130.4K | 4.08M | 62.53% | ↗ |
| 36 | 2020 | Roman Trawicki EVP, President of Global Manufacturing and Supply | 675.0K | — | 974.8K | 325.0K | 641.0K | 874.5K | 3.49M | 37.24% | ↗ |
| 37 | 2020 | Catherine A. Knupp EVP, President of Research and Development | 710.0K | — | 1.35M | 450.0K | 658.9K | 137.1K | 3.31M | 54.45% | ↗ |
| 38 | 2019 | Glenn C. David EVP and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance since June 1, 2021; EVP and CFO until May 31, 2021 | 690.0K | — | 1.61M | 537.5K | 695.5K | 136.9K | 3.67M | 58.54% | ↗ |
| 39 | 2019 | Kristin C. Peck Chief Executive Officer | 690.0K | — | 1.35M | 450.0K | 695.5K | 144.7K | 3.33M | 54.05% | ↗ |
| 40 | 2019 | Catherine A. Knupp EVP, President of Research and Development | 690.0K | — | 1.35M | 450.0K | 679.0K | 142.3K | 3.31M | 54.36% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kristin C. Peck | Chief Executive Officer & Director | 5M | female |
| Wetteny N. Joseph | Executive Vice President & Chief Financial Officer | 2M | male |
| Jamie Brannan | Executive Vice President & Chief Commercial Officer | 2M | male |
| Robert J. Polzer | Scientific Advisor | 1M | — |
| Roxanne Lagano | Executive Vice President, General Counsel & Corporate Secretary | 1M | female |
| Julie A. Fuller | Executive Vice President, Chief Human Resources Officer & Global Operations | — | female |
| Nick Ashton | Executive Vice President and President of Global Manufacturing & Supply | — | male |
| Keith Sarbaugh | Executive Vice President & Chief Digital and Technology Officer | — | male |
| Steven Frank | Vice President of Investor Relations | — | male |
| Jeannette Ferran Astorga | Executive Vice President of Corporate Affairs & Chief Sustainability Officer | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-12-05 | Markwayne Mullin | OK | Joint | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2025-11-10 | 2025-12-05 | Markwayne Mullin | OK | Joint | Sale | $15,001 - $50,000 | ↗ |
| 2025-05-13 | 2025-06-11 | Markwayne Mullin | OK | Joint | Purchase | $50,001 - $100,000 | ↗ |
| 2025-04-08 | 2025-05-12 | Markwayne Mullin | OK | Joint | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2025-04-08 | 2025-05-13 | Markwayne Mullin | OK | Joint | Sale | $15,001 - $50,000 | ↗ |
| 2024-04-03 | 2025-08-12 | Markwayne Mullin | OK | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2024-04-03 | 2025-08-13 | Markwayne Mullin | OK | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2024-02-27 | 2024-03-15 | Shelley Moore Capito | WV | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2024-01-04 | 2024-01-26 | Markwayne Mullin | OK | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-03 | 2023-11-01 | Markwayne Mullin | OK | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2023-09-13 | 2023-10-12 | Markwayne Mullin | OK | Joint | Purchase | $15,001 - $50,000 | ↗ |
| 2023-08-22 | 2023-09-22 | Dan Sullivan | AK | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2023-01-10 | 2023-02-13 | Dan Sullivan | AK | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2022-11-30 | 2023-07-26 | Dan Sullivan | AK | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2022-10-05 | 2022-11-10 | Tommy Tuberville | AL | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2015-01-30 | 2016-08-13 | David Perdue | — | Joint | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2015-01-29 | 2016-08-13 | David Perdue | — | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2015-01-14 | 2016-08-13 | David Perdue | — | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-03-10 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-12-19 | 2026-01-12 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-11-18 | 2025-12-15 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-27 | 2025-11-14 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-07 | 2025-11-14 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2025-10-06 | 2025-10-17 | Rick Larsen | WA02 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-09-29 | 2025-10-03 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-09-26 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-09-15 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-09-05 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-27 | 2025-09-12 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-08-26 | 2025-09-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-21 | 2025-09-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-06 | 2025-09-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-05 | 2025-09-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-05 | 2025-09-12 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-08-04 | 2025-09-12 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-15 | 2025-06-02 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-04-08 | 2025-04-29 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZTS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
